Sullivan Mark
Definium Therapeutics, Inc. · Chief Legal Officer
Sullivan Mark is listed in filings as Chief Legal Officer at Definium Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including sale activity. Recent filings connect the profile to Definium Therapeutics, Inc. (DFTX). The current snapshot covers public activity from Jun 25, 2024 to Jun 22, 2026. Reported amounts are shown as $128.9K to $33.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $129k17.9k shares | SellJun 25, 2024 | $7.22 | $36.67 | |
| $26k4.4k shares | SellSep 25, 2024 | $5.98 | $36.67 | |
| $34k4.5k shares | SellDec 26, 2024 | $7.43 | $36.67 | |
| $44k6.6k shares | SellMar 25, 2025 | $6.74 | $36.67 | |
| $78k11.5k shares | SellJun 25, 2025 | $6.80 | $36.67 | |
| $110k11.3k shares | SellSep 25, 2025 | $9.77 | $36.67 | |
| $148k11.3k shares | SellDec 26, 2025 | $13.15 | $36.67 |